Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Issue 11 (26th October 2018)

• Record Type: Journal Article
• Authors: Fox, Rina S.; Kwakkenbos, Linda; Carrier, Marie‐Eve; Mills, Sarah D.; Gholizadeh, Shadi; Jewett, Lisa R.; Roesch, Scott C.; Merz, Erin L.; Assassi, Shervin; Furst, Daniel E.; Gottesman, Karen; Mayes, Maureen D.; Thombs, Brett D.; Malcarne, Vanessa L.
• Other Names: Baron Murray investigator.; Bartlett Susan J. investigator.; Ells Carolyn investigator.; Hudson Marie investigator.; Jang Yeona investigator.; Körner Annett investigator.; Kafaja Suzanne investigator.; van den Hoogen Frank investigator.; Mouthon Luc investigator.; Nielson Warren R. investigator.; Riggs Robert investigator.; Nielsen Karen investigator.; Wigley Fredrick investigator.; Boutron Isabelle investigator.; Maia Angela Costa investigator.; Leite Catarina investigator.; El‐Baalbaki Ghassan investigator.; van den Ende Cornelia investigator.; Fligelstone Kim investigator.; Frech Tracy investigator.; Godard Dominique investigator.; Harel Daphna investigator.; Impens Ann investigator.; Johnson Sindhu R. investigator.; Kennedy Ann Tyrell investigator.; Khalidi Nader investigator.; Marra Carlo investigator.; Pope Janet investigator.; Portales Alexandra investigator.; Luna David investigator.; Schouffoer Anne A. investigator.; Levis Brooke investigator.; Suarez‐Almazor Maria E. investigator.; Welling Joep investigator.; Wong‐Rieger Durhane investigator.; Agard Christian investigator.; Ikic Alena investigator.; Smets Perrine investigator.; Roux Sophie investigator.; Terrier Benjamin investigator.; Hij Adrian investigator.; Berthier Sabine investigator.; Rodriguez Esther investigator.; Chung Lorinda investigator.; Gill Anna investigator.; Domsic Robyn investigator.; Wilcox Pearce investigator.; Fortin Paul R. investigator.; Spiera Robert investigator.; Granel‐Rey Brigitte investigator.; Grange Claire investigator.; Sobanski Vincent investigator.; Herrick Ariane L. investigator.; Varga John investigator.; Jones Niall investigator.; Manning Joanne investigator.; Martin Thierry investigator.; Maurier François investigator.; Rivière Sébastien investigator.; Robinson David investigator.; Smith Doug investigator.; Steen Virginia investigator.; Sutton Evelyn investigator.; Thorne Carter investigator.; Turner Kimberly investigator.;
• Is Part Of: Arthritis care & research. Volume 70:Issue 11(2018)
• Page Start: 1646
• Page End: 1652
• Publication Date: 2018-10-26
• Subjects: Arthritis -- Periodicals; Rheumatism -- Periodicals; 616.72
• DOI: 10.1002/acr.23532
• Languages: English
• ISSNs: 2151-464X

Abstract

Abstract : Objective: Fear of negative evaluation is a common concern among individuals with visible differences but has received limited attention in systemic sclerosis (SSc), which can involve substantial changes to appearance. The Brief Fear of Negative Evaluation Scale (BFNE) was specifically designed to evaluate fear of negative evaluation. There are currently 3 versions of the BFNE with strong demonstrated measurement properties: two 8‐item versions (BFNE‐S, BFNE‐8) and one 12‐item version (BFNE‐II). The present study evaluated these versions in SSc, and identified the most appropriate version for use among SSc patients. Methods: Participants were 1, 010 patients with SSc enrolled in the Scleroderma Patient‐Centered Intervention Network cohort. Multiple group confirmatory factor analysis, Cronbach's alpha, and Pearson's product‐moment correlations were used to evaluate structural validity, internal consistency reliability, and convergent and divergent validity, respectively. Results: Confirmatory factor analysis demonstrated that 1‐factor models fit acceptably well for the 12‐item BFNE‐II, the 8‐item BFNE‐S, and the 8‐item BFNE‐8. Additionally, all Cronbach's alphas demonstrated excellent internal consistency reliability (BFNE‐II = 0.98, BFNE‐S = 0.97, BFNE‐8 = 0.96), and all versions had comparable associations with measures of social anxiety, body‐related attitudes, depression, age, and education. Conclusion: Psychometric support was found for all 3 versions of the BFNE, although the longer 12‐item BFNE‐II did not improve measurement compared to the shorter 8‐item versions (BFNE‐S and BFNE‐8). Of these 2, the BFNE‐S has been more widely studied, with strong validity data in a greater number of populations. Therefore, the BFNE‐S is recommended to assess fear of negative evaluation among patients with SSc.